IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,188 | -35.4% | 1,360,000 | 0.0% | 0.08% | -31.5% |
| Q2 2023 | $9,574 | +15.2% | 1,360,000 | 0.0% | 0.12% | +8.8% |
| Q1 2023 | $8,310 | -4.4% | 1,360,000 | 0.0% | 0.11% | -0.9% |
| Q4 2022 | $8,690 | -99.9% | 1,360,000 | +17.2% | 0.12% | -24.8% |
| Q3 2022 | $11,113,000 | -13.2% | 1,160,000 | 0.0% | 0.15% | -5.0% |
| Q2 2022 | $12,806,000 | +494.0% | 1,160,000 | +411.7% | 0.16% | +496.3% |
| Q1 2019 | $2,156,000 | +7.5% | 226,681 | 0.0% | 0.03% | -6.9% |
| Q4 2018 | $2,006,000 | -55.5% | 226,681 | -43.4% | 0.03% | -50.0% |
| Q3 2018 | $4,507,000 | -8.7% | 400,603 | +3.9% | 0.06% | -14.7% |
| Q2 2018 | $4,934,000 | – | 385,446 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |